Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase
Abstract As the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic engulfs millions worldwide, the quest for vaccines or drugs against the virus continues. The helicase protein of SARS-CoV-2 represents an attractive target for drug discovery since inhibition of helicase activity c...
Guardado en:
Autores principales: | Syed Hani Abidi, Nahlah Makki Almansour, Daulet Amerzhanov, Khaled S. Allemailem, Wardah Rafaqat, Mahmoud A. A. Ibrahim, Philip la Fleur, Martin Lukac, Syed Ali |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea2e046f6fae47038f43803a996a9f1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Computational drug repurposing study elucidating simultaneous inhibition of entry and replication of novel corona virus by Grazoprevir
por: Santosh Kumar Behera, et al.
Publicado: (2021) -
Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial
por: Zhdanov K, et al.
Publicado: (2020) -
Challenges of Offering a MOOC from an LMIC
por: Aamna Pasha, et al.
Publicado: (2016) -
Evaluation of the role of itraconazole and posaconazole in viral infection as immunomodulatory drugs
por: Falah Hasan Obayes Al-Khikani
Publicado: (2021) -
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
por: F. Yuan, et al.
Publicado: (2021)